21-40 of 2468 < first | | | last >
  • Tech Transfer Communications

    Transitioning from “forming and storming” to the desired “norming and performing” stages of project execution

    Achilles Cortez, Senior Director of Project Management, Pharma Tech Industries
  • The MLCM Paradigm Shift

    Analytical methods based on performance are quickly becoming a compliance expectation

    Dr. Alexander H. Schmidt, CEO and joint founder, Chromicent, Mijo Stanic, CEO and joint-founder, Chromicent, and Dr. Paula Hong, Principal Consulting Scientist, Waters Corporation
  • Generics Surge Forward

    AAM Access! 2019 makes it clear that generics have earned their seat at the table

    Karen Langhauser, Chief Content Director
  • Preparing for the Upsurge in Pharma Cyber Attacks

    In 2019, the number of connected OT devices will continue to grow exponentially and so will the OT security threat landscape.

    Yoni Shohet, Co-founder and VP of Business Development, SCADAfence
  • Excipients Fit for 21st Century Medicine

    DuPont's novel excipient is designed to better stabilize biologics

    Joshua S. Katz, Abigail Nolin, Benjamin A. Yezer, and Susan Jordan, DuPont Nutrition and Health
  • The Case for Predictive Maintenance

    Leveraging data will not only help pharma predict asset failures, but also eliminate them

    Sean Otto, Ph.D., VP Analytics, Cyient Insights
  • The Case for Outsourcing Buffer Preparation in Pharma

    Why manufacturers are seeking alternative options to in-house preparation.

    Dr. Becky Moore, Senior Global Product Manager Bioprocess Liquids; Genevieve E. Brau, Senior Manager, Global Market Development; Remko Clasen, Senior Market Development Manager, Thermo Fisher Scientific
  • Spotlight on Data Integrity

    How laboratory information management systems are helping pharma stay compliant

    Kimberly Remillard, Senior Regulatory Affairs Specialist for Digital Science, Thermo Fisher Scientific
  • Changing Cupid's Contract

    Pharma CMOs are sharpening their arrows and getting noticed

    Karen Langhauser, Chief Content Director
  • Sustainable Drugs From the Start

    China-based Porton Pharma’s partnership with Codexis will bring new and improved manufacturing routes for APIs

    Karen Langhauser, Chief Content Director
  • CMOs on Fire

    Four contract manufacturers who are redefining what it means to outsource

  • Build Biologics Not Barriers

    iBio’s unique partnership with Beijing’s CC-Pharming will bring economical, plant-derived rituximab to China

    Karen Langhauser, Chief Content Director
21-40 of 2468 < first | | | last >